MTL-CEBPA
2020/00223
Phase 1 small_molecule active
Quick answer
MTL-CEBPA for Advanced Hepatocellular Carcinoma is a Phase 1 program (small_molecule) at Hospital Authority, Hong Kong with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Hospital Authority, Hong Kong
- Indication
- Advanced Hepatocellular Carcinoma
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active